Hyeda Adriano, Costa Élide Sbardellotto Mariano da
Universidade Federal do Paraná, Curitiba, PR, Brazil.
Instituto Superior de Administração e Economia, Fundação Getúlio Vargas, Curitiba, PR, Brazil.
Einstein (Sao Paulo). 2017 Apr-Jun;15(2):192-199. doi: 10.1590/S1679-45082017GS4002.
To conduct an economic analysis of enteral and parenteral diet costs according to the type of disease and outcome (survivors versus deaths).
It is a cross-sectional, observational, retrospective study with a qualitative and quantitative design, based on analysis of hospital accounts from a healthcare insurance provider in the Southern region of Brazil.
We analyzed 301 hospital accounts of individuals who used enteral and parenteral diets. The total cost of the diet was 35.4% of hospital account total costs. The enteral modality accounted for 59.8% of total dietary costs. The major costs with diets were observed in hospitalizations related to infections, cancers and cerebro-cardiovascular diseases. The major costs with parenteral diet were with admissions related by cancers (64.52%) and dementia syndromes (46.17%). The highest ratio between total diet costs with the total of hospital account costs was in dementia syndromes (46.32%) and in cancers (41.2%). The individuals who died spent 51.26% of total of hospital account costs, being 32.81% in diet (47.45% of total diet value and 58.81% in parenteral modality).
Enteral and parenteral nutritional therapies account for a significant part of the costs with hospitalized individuals, especially in cases of cancers and dementia syndromes. The costs of parenteral diets were higher in the group of patients who died.
Realizar uma análise econômica de custos da terapia nutricional enteral e parenteral, conforme o tipo de doença e o desfecho (sobreviventes versus óbitos).
MÉTODOS: Estudo transversal, observacional, retrospectivo, com estratégia qualitativa e quantitativa, a partir da análise de contas hospitalares de uma operadora de saúde da Região Sul do Brasil.
Foram analisadas 301 contas hospitalares de usuários que utilizaram dieta enteral e parenteral. O custo total com dieta foi de 35,4% do custo total das contas hospitalares. A modalidade enteral representou 59,8% do custo total em dieta. Os maiores custos com dieta foram observados em internações relacionadas a infecções, cânceres e doenças cérebro-cardiovasculares. Os maiores custos com dieta parenteral foram observados nas internações relacionadas aos cânceres (64,52%) e às síndromes demenciais (46,17%). A maior relação entre o custo total com dieta e o custo total da conta foi na síndrome demencial (46,32%) e no câncer (41,2%). Os usuários que foram a óbito consumiram 51,26% dos custos totais das contas, sendo 32,81% com dieta (47,45% do valor total com dieta e 58,81% do custo na modalidade parenteral).
CONCLUSÃO: As terapias nutricionais enteral e parenteral representaram uma parte importante dos custos no tratamento de indivíduos hospitalizados, principalmente nos casos dos cânceres e nas síndromes demenciais. O custo com dieta parenteral foi maior no grupo de usuários que foram a óbito.
根据疾病类型和结局(存活者与死亡者)对肠内和肠外饮食成本进行经济分析。
这是一项采用定性和定量设计的横断面、观察性、回顾性研究,基于对巴西南部一家医疗保险机构的医院账目分析。
我们分析了301例使用肠内和肠外饮食的个体的医院账目。饮食总成本占医院账目总成本的35.4%。肠内方式占饮食总成本的59.8%。饮食的主要成本见于与感染、癌症和心脑血管疾病相关的住院病例。肠外饮食的主要成本见于与癌症相关的入院病例(64.52%)和痴呆综合征相关的入院病例(46.17%)。饮食总成本与医院账目总成本之间的最高比例见于痴呆综合征(46.32%)和癌症(41.2%)。死亡个体花费了医院账目总成本的51.26%,其中饮食花费占32.8(占饮食总价值的47.45%,肠外方式花费占58.81%)。
肠内和肠外营养治疗在住院个体的治疗成本中占很大一部分,尤其是在癌症和痴呆综合征病例中。死亡患者组的肠外饮食成本更高。
根据疾病类型和结局(存活者与死亡者)对肠内营养治疗和肠外营养治疗的成本进行经济分析。
采用横断面、观察性、回顾性研究,运用定性和定量策略,基于对巴西南部一家健康保险公司的医院账目分析。
分析了301例使用肠内和肠外饮食的用户的医院账目。饮食总成本占医院账目总成本的35.4%。肠内方式占饮食总成本的59.8%。饮食的主要成本见于与感染、癌症和心脑血管疾病相关的住院治疗。肠外饮食的主要成本见于与癌症相关的住院治疗(64.52%)和痴呆综合征相关的住院治疗(46.17%)。饮食总成本与账目总成本之间的最高比例见于痴呆综合征(46.32%)和癌症(41.2%)。死亡用户花费了账目总成本的51.26%,其中饮食花费占32.81%(占饮食总价值的47.45%,肠外方式花费占58.81%)。
肠内营养治疗和肠外营养治疗在住院个体的治疗成本中占重要部分,主要是在癌症和痴呆综合征病例中。死亡用户组的肠外饮食成本更高。